Advertisement
Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of ChinaMedicine Corporation, will be Mr. Fred Cheung, Chief Financial Officer. TheCompany plans to issues its earnings release prior to the call.
Advertisement
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time:1-800-688-0796. International callers should dial 1-617-614-4070, ConferencePasscode: 10924041.
If you are unable to participate in the call at this time, a replay willbe available for 14 days starting on Thursday, May 13, at 11:00 p.m. EasternTime. To access the replay, dial 1-888-286-8010, international callers dial1-617-801-6888, and enter the passcode of 97174060.
About China Medicine Corporation
China Medicine Corporation, a comprehensive enterprise with a research anddevelopment centre, manufacturing facilities and well established salesnetwork, engages in the production and distribution of prescription and overthe counter ("OTC") drugs, traditional Chinese medicine products, herbs anddietary-supplements, medical devices, and medical formulations in China. TheCompany distributes its products to wholesale distributors, including morethan 300 hospitals and 500 medicine companies that sell to over 2,000 drugstores in 28 provinces throughout China. The Company is developing a number ofproprietary products for a variety of uses, including oncology, high bloodpressure and the removal of toxins from food and animal feeds.For more information, please contact: Company Contact: Gavin Chen Assistant to CFO China Medicine Corporation Tel: +86-20-8737-2102 Email: [email protected] Investor Relations Contact: Ms. Lei Huang, Account Manager CCG Investor Relations Tel: +1-646-833-3417 (NY Office) Email: [email protected] Web: http://www.ccgirasia.com Mr. Crocker Coulson, President CCG Investor Relations Tel: +1-646-213-1915 Email: [email protected]
SOURCE China Medicine Corporation
